Abstract: An indirect competitive ELISA has been developed for the determination of Norfloxacin (NFLX) residue in chicken liver. For this reason, carbodiimide active ester method was employed to synthesize the artificial antigen of NFLX-BSA, and coating antigen of NFLX-OVA, and rabbits were used to produce the anti-NFLX polyclonal antibody. Based on the square matrix titration, an icELISA method was developed for the quantitative detection of NFLX. The dynamic range was from 0.006 to 38 ng/mL, with LOD and IC 50 value of 0.004 ng/mL and 0.48 ng/mL, respectively. Except for a high cross-reactivity to Ciprofloxacin (38%) and Sarafloxacin (33%), negligible cross-reactivity to the other compounds was observed. After optimization, 10-fold dilution in chicken liver extract gave an inhibition curve almost the same as that in PBS buffer. When spiked in liver extract at 8, 20, and 50 ng/mL, the recovery rate was 90-117.8% for intraassay, and 97.5-114.4% for inter-assay, respectively. The relative standard deviation ranged from 5.6-9.2% for intraassay and 5.9-11% for inter-assay. Therefore, the developed icELISA method could be used for the routing screening of NFLX residues in chicken edible tissues.
INTRODUCTION
Fluoroquinolones (FQs) are an important group of synthetic antimicrobials with a broad spectrum antibacterial activity, good absorption after oral administration, and extensive tissue distribution [1] . FQs act via inhibition of DNA-gyrase, abolishing its activity by interfering with the DNA rejoining reaction. Because gyrase is an essential eznyme in prokaryotes, but not found in eukaryotes, bacteria are an ideal target for these antibiotics [2] . Therefore, FQs have found widespread application in the treatment and prevention of veterinary diseases in food-producing animals, and they have even been used as growth-promoting agents.
The wide range of applications and possibility of abuse or misuse of FQs present potential hazards to human health, such as the emergence and spread of drug-resistant bacterial strains and possible induction of cancer [3] . Because of concerns about drug residues entering the food chain and contributing to bacterial resistance, the European Union (EU) established maximum residue levels (MRLs) for various classes of antibiotics including FQs in different food matrices of animal origin and from various species [4] . In China, the species of animal, usage, dosage, and withdrawal period for FQs have been determined by the Ministry of Agriculture of the People's Republic of China (no. 278, 2003.5.22) [5] .
So far, classical analytical methods have been described for the detection of FQs in tissues, including high performance liquid chromatography (HPLC) [6] [7] , liquid chromatography-mass spectrometry (LC-MS) [8] [9] , and LC-MS/MS [10] [11] [12] . These methods require extensive sample preparation as well as highly trained individuals to operate sophisticated instruments and interpret complicated chromatograms or spectral results. Consequently, these traditional methods, although highly accurate, are timeconsuming, costly, and generally not suitable for use in the field. Therefore, it was necessary to develop simple, rapid, inexpensive, and efficient methods for monitoring FQs residues. Numerous immunoassay studies have thus been reported for the detection of FQs, including Enrofloxacin [13] , Norfloxacin [14] , and Pefloxacin [15] .
Norfloxacin (NFLX) is a synthetic antibacterial agent that belongs to the fluoroquinolone group, and Cooking procedures do not affect NFLX residues, which remain stable during heating. This paper describes the development of a polyclonal antibody-based screening method (ELISA) aimed at the determination of NFLX residues in chicken.
II. MATERIALS AND METHODS

A. Materials and reagents
Norfloxacin, Ciprofloxacin, Enrofloxacin, Sarafloxacin, Ofloxacin, Pefloxacin, Lomefloxacin and Danofloxacin were provided by Sigma (St. Louis, MO). BSA, OVA and GaRIgG-HRP were purchased from Sino-American Biotechnology Company (Shanghai, China). FCA, FIA and EDC were obtained from Pierce. NHS was from Japan, MSDS available. O-(Carboxymethyl) hydroxylamine hemihydrochloride, Succinic anhydride, were supplied by Sigma while Dialysis bag was from Solarbio Company. TMB, phenacetin, urea peroxide were obtained from Sigma Company. All other solvents and reagents were of analytical grade or higher, unless otherwise stated. A spectrophotometric microtitre reader, MULTISKAN MK3 (Thermo company, USA), provided with a 450 nm filter, was used for absorbance measurements.
Female New Zealand white rabbits were obtained from the Laboratory Animal Center, Beijing Medical University, and raised under strictly controlled conditions in our laboratory chamber. (15 mM) , NaHCO 3 (35 mM), pH 9.6; washing buffer consisted of PBS containing 0.05% Tween-20; blocking buffer contained BSA (1%, w/v) in PBS buffer. Assay buffer consisted of adding part A (500 mL) and part B (500 mL) solutions together. Part A contained (per 1 L of water) 3.15 g of citric acid, 6.966 g of anhydrous sodium acetate, 0.08 g phenacetin and 0.05 g of urea peroxide adjusted to pH 5 with HCl. Part B contained 1.27 g TMB dissolved in 500 mL of methanol and 500 mL of glycerol. The stopping solution was 2 M H 2 SO 4 .
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C. Preparation of immunogen and coating antigen
The immunogen of NFLX-BSA and coating antigen of NFLX-OVA were prepared by carbodiimide-modified active ester method as described in the literature [5] . In this procedure, a solution of 9.8 mg of NFLX (23 μmol), 44.7 mg of EDC (230 μmol), and 13.4 mg of NHS (117μmol) in 3.0 mL of DMF was incubated for 24 h at room temperature in the dark. To this solution, 67 mg of BSA (1 μmol) dissolved in 10 mL of PBS (0.01 M, pH 7.4) was added slowly under stirring, followed by incubation at room temperature for 3 h. The reaction mixture was dialyzed under stirring against PBS for 6 days with frequent change of PBS solution to remove the uncoupled free hapten. The solution was lyophilized, and NFLX-BSA obtained was stored at -20℃. A NFLX-OVA conjugate was prepared in a similar method.
D. Immunization of rabbits
Two Female New Zealand white rabbits were subcutaneously immunized at multiple sites in the back with NFLX-BSA conjugate. The initial immunization was injected with 500 μg of conjugate in 0.5 mL of PBS and 0.5 mL of FCA. Subsequent booster injections (0.5 mg of conjugate in 0.5 mL of PBS plus 0.5 mL of FIA) were performed three weeks later and then at 15 days intervals. Ten days after the last boost, all rabbits were exsanguinated by heart puncture under general anesthetic. The antiserum was prepared by allowing the blood to clot overnight at 4 ℃, followed by centrifugation with 10000 rpm for 20 min to remove particulate materials. The crude serum was purified by saturated ammonium sulfate (SAS) precipitation method (purified three times using 50, 33, and 33% (v/v) of SAS, respectively). The purified serum was then aliquotted and stored at -70 ℃.
E. Antibody titer determination by indirect ELISA
The microplates were coated with coating antigen NFLX-OVA at 2 μg/mL in CBS (100 μL/well) by overnight incubation at 4 ℃. Plates were washed with PBST three times and blocked with 250 μL/well of blocking buffer, followed by incubation for 1 h at 37 ℃. After washing three times again, the appropriate dilution of the antisera was added, and the plates were incubated for 15 min at 37 ℃. Then the plates were washed three times, and GaRIgG-HRP (1:1000, 50 μL/well) was added, followed by incubation for 25 min at 37 ℃ in a DH-360A oven. Plates were washed again as above and 60 μL/well of TMB substrate solution was added, followed by incubation for 15 min at room temperature. The enzymatic reaction was stopped with sulfuric acid (2 M, 100 μL/well) and the yellow plate was spectrophotometrically read in a single wavelength mode at 450 nm. Preimmune withdrew serum was used as a negative control, and the antibody titer was defined as the reciprocal of the dilution that resulted in an absorbance value that was twice that of the background.
F. Development of indirect competitive ELISA
The checkerboard procedure was used to optimize the coating antigen and the primary antibody concentrations, resulting in the following optimized protocol. To each well of a 96 well plate, 100 μL of selected coating antigen was added and incubated for 2 h at 37 ℃. The plate was washed three times and blocked with 250 μL/well of blocking buffer, followed by incubation for 1 h at 37 ℃. After another washing procedure, varying concentrations of NFLX or competitor (50 μL/well) was added, followed by equal volume of NFLX antiserum previously diluted in PBS. The following steps were similar to the indirect ELISA described above. Absorbances were corrected by blank reading and the results were expressed in percent inhibition as follows: % inhibition ＝ (OD max -OD min ) -(OD x -OD min )/ (OD max -OD min ) ×100%, where OD max is the optical density of the well without competitor, OD x is the optical density of the well containing competitor and OD min is the optical density of blank well. The cross-reactivity (CR) was calculated as: (IC 50 of NFLX)/ (IC 50 of competitors) ×100. The lower the CR is, the higher the specificity of NFLX pAb is.
G. Chicken liver extract preparation
Minced samples (5 g) of NFLX-free (determined by high-performance liquid chromatography) chicken liver were homogenized with 5 mL of extraction solvent consisting of a 1:5 (v/v) mixture of methanol and PBS adjusted to pH 7.4 with 6 N HCl. The homogenates were mixed on a vortex mixer for 30 s, vigorously shaken for 30 min, and then centrifuged at 10000 rpm for 20 min. The supernatants were diluted by a factor (2, 5, 10, and 20) in the assay before they were applied to the microtiter plate.
H. Precision and accuracy
Precision was expressed as the relative standard deviation (R.S.D.) and accuracy was expressed as the recovery data of the estimated concentration. Intra-and inter-assay detection of the overall analytical procedure was determined by spiking a pool of negative liver samples with three different NFLX concentrations (low 8 ng/mL, medium 20 ng/mL, high 50 ng/mL) based on the icELISA calibration curve. To determine the intra-precision, triplicate spiked samples were analyzed on six different day, while the interprecision was determined from triplicate runs of six samples on a single day.
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Ⅲ.
RESULTS AND DISCUSSIONS
A. Immunogen and coating antigen Synthesis
As a small molecule, Norfloxacin (MW= 361＜1000 Da) has to be conjugated with a carrier protein in order to stimulate the immune response of an animal to produce the anti-NFLX antibody. Among carrier proteins, BSA and OVA are two of the most often used ones, and usually, they give satisfying results. The free carboxylic acid group on NFLX was linked to amino groups on BSA and OVA using carbodiimide as reported in our study (Fig. 1) . This reaction resulted in an amide bond between the NFLX and the carrier protein. UV absorbances were measured for BSA, NFLX and NFLX-BSA, respectively. The absorbance peaks at 323 and 334 nm, coming from the absorbances of quinolone moiety of NFLX, have shifted to 319 and 331 nm of NFLX-BSA in UV spectrometry, indicating the successful conjugation. The coating antigen gives a similar UV pattern as immunogen. 
B. Establishment of the indirect competitive ELISA
The titer of antibody was determined by indirect ELISA as ＞ 51200 for both rabbits used in the immunization process, with the titer being defined as the reciprocal of the dilution that results in an absorbance value that is twice that of the background. The antibody was evaluated for its ability to bind to NFLX, and the representative icELISA curve is shown in Fig. 2 . obtained by averaging three independent curves, each run in triplicate. NFLX-OVA (2 μg/mL) as coating antigen was prepared in CBS (pH 9.6), purified anti-serum produced by NFLX-BSA as immunogen was diluted 1:20,000 in PBS (pH 7.4), NFLX was prepared in PBS, containing 10% methanol, GaRIgG-HRP was diluted 1:1000 in incubation buffer.
The following parameters were calculated to identify the icELISA. The dynamic range for the ELISA was calculated as the concentration of the analyte providing a 20-80% inhibition rate (IC 20 -IC 80 values) of the maximum signal, and the data ranged from 0.006 to 38 ng/mL. Sensitivity was evaluated using the IC 50 values, which represented the concentration of NFLX that produced 50% inhibition rate, and it was calculated as 0.48 ng/mL. The detection of limit (LOD) of this assay, which represented a signal of 15% inhibition rate [16] , was 0.004 ng/mL.
C. Specificity of the immunoassay
The specificity of the immunoassay was evaluated by determination of the cross-reactivity toward various FQs. The cross-reactivity studies were carried out by icELISA by adding various free competitors at different concentrations (from 0.01 to 2000 ng/mL) to compete with binding of the antibody to the coating antigen. The value was measured by comparison of the IC 50 of the competitor with that of NFLX.
The anti-NFLX antibody shows fairly good specificity with significant cross-reactivity only toward a few drugs, and the results are shown in table 1. In our research, the immunogen was synthesized by the linkage of carboxylic acid group of NFLX with amino group of the carrier protein (Fig. 1) . In this linkage, the furthest group of NFLX from the linkage point is the piperazinyl moiety. Therefore, it is not a surprise that Ciprofloxacin (38%) and Sarafloxacin (33%) show high cross-reactivities with antibody because both of them have the same groups connected to the piperazine moieties through a nitrogen atom.
In the FQs family, current research could not reach a clear conclusion on where a substituent is a more important structural factor to determine the affinity of a drug toward an antibody. Although further careful designed study is necessary to clarify the issue, we believe that both electronic and three-dimensional structures should be considered before the problem can be elucidated clearly in the further.
D. Matrix effects
It has been known that various substances existing in complex matrixes can affect antigen-antibody interaction in immunoassays. Dietary components, higher ionic strengths and the pH parameters at more acidic or basic values also strongly suppress the IC 50 value and the maximum V1-462 absorbance. In our study, the effects were estimated by maximum absorbance (A max , the absorbance value at zero concentration of NFLX) and half-maximum inhibition concentration (IC 50 , the value represents the concentration of NFLX that produce 50% inhibition), and the maximal A max /IC 50 ratio was chosen [17] . The results are shown in Fig. 3 . It can be concluded the 10-fold dilution is suitable for the immunoassay. 
E. Precision and accuracy
The applicability of the developed assay in the determination of NFLX residue in chicken liver was tested, and the results obtained are shown in Table 2 . 4 11 In this research, samples for the precision and accuracy studies were prepared by the 10-fold dilution of the extract in PBS for any further treatment. The liver sample spiked at 8, 20 and 50 ng/mL gave an average recovery rate of 90, 106.5, and 117.8% for intra-assay and 97.5, 118, and 114.4% for inter-assay, respectively. The R.S.D ranged from 5.6-9.2% for intra-assay and 5.9-11% for inter-assay.
It can be concluded, we have prepared a high-quality polyclonal antibody for NFLX. The icELISA based on this antibody shows high sensitivities toward NFLX, and the ELISA developed in this study could be used for the routing screening of Norfloxacin residues in chicken edible tissues.
